Ventyx Biosciences logo
Ventyx Biosciences, Inc. (VTYX)
Mar 4, 2026 - VTYX was delisted (reason: acquired by LLY)
14.00
+0.02 (0.14%)
Inactive · Last trade price on Mar 3, 2026

Ventyx Biosciences Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Ventyx Biosciences stock had an average target of $13.5, with a low estimate of $11 and a high estimate of $14.

Price Target: $13.5 (-3.57%)
Analyst Consensus: Hold

Price Target

TargetLowAverageMedianHigh
Price$11$13.5n/a$14
Change-21.43%-3.57%n/a0.00%

Analyst Ratings

The average analyst rating for Ventyx Biosciences stock from 7 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.48
from -1.97
EPS Next Year
-1.74
from -1.48
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
EPS
-14.17-6.65-2.07-3.30-1.97-1.48-1.74
No. Analysts
-----1010

Revenue Forecast

Revenue202520262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS202520262027202820292030
High-1.42-1.20
Avg-1.48-1.74
Low-1.54-2.20

EPS Growth

EPS Growth202520262027202820292030
High--
Avg--
Low--